HER2 Support Group Forums - View Single Post - LUNGevity Foundation welcomes FDA approval of Zykadia for advanced stages of lung can

News · 05-02-2014, 12:13 AM

LUNGevity Foundation applauds the FDA approval of Zykadia™ for the subset of anaplastic lymphoma kinase-positive (ALK+) patients with advanced cases of non-small cell lung cancer who have progressed on or are intolerant to crizotinib.

More...

05-02-2014, 12:13 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,983	LUNGevity Foundation welcomes FDA approval of Zykadia for advanced stages of lung can LUNGevity Foundation applauds the FDA approval of Zykadia™ for the subset of anaplastic lymphoma kinase-positive (ALK+) patients with advanced cases of non-small cell lung cancer who have progressed on or are intolerant to crizotinib. More...